St. Jude Outlines Strategy To Revive Pacemaker Business
St. Jude Medical’s pacemaker revenue dropped 12 percent year-over-year in the first quarter, but the firm says it has several products in the pipeline that could help it regain pacemaker market share in Europe and Japan.
St. Jude Medical Inc. offered more detail on its plans to turn around its sagging fortunes in the pacemaker market April 17.
During the company’s first-quarter earnings call, CEO Dan Starks explained several developments that he is optimistic “will make a very...
